Fatih Turkmen
Research Subjects
Fatih Turkmen has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Aslı Çanakçı
Department of Medical Services and Techniques, Aydın Vocational School of Health Services, Aydın Adnan Menderes University, Aydın 09000, Türkiye
1 shared publication - Behcet Al
İstanbul Medeniyet Üniversitesi
1 shared publication - Ferhat Şirinyıldız
Department of Physiology, Faculty of Medicine, Aydın Adnan Menderes University, Aydın 09000, Türkiye
1 shared publication - Kenan Ahmet Turkdogan
Adnan Menderes University, Department of Emergency Medicine, Aydin, Turkey
1 shared publication - Selçuk Eren Çanakçı
Department of Emergency Medicine, Faculty of Medicine, Aydın Adnan Menderes University, Aydın 09000, Türkiye
1 shared publication - Simge Ünay
Department of Biophysics, Faculty of Medicine, Uşak University, Uşak 64000, Türkiye
1 shared publication
Latest Publications
- Open Access
- 7 November 2026
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (11) , 1179
Cellular Effects of a Topical Hemostatic Agent Used for Acute Bleeding Control: An in Vitro Study in MCF-7 and HEK-293 Cells
This exploratory in vitro study characterized 24 h responses to the topical hemostatic formulation Blood Stoper (TE’SIR) in MCF-7 and HEK-293 cells. Relative MTT reduction was assessed over 0.5–75% (v/v); qualitative scratch-gap observations and 24 h stained-cell aggregate counts were obtained in MCF-7 cells at 0.5%, 1%, and 7.5%, and supernatant malondialdehyde (MDA) and catalase readouts were obtained in both lines. In MCF-7 cells, the reported relative MTT signal declined from 72.61% at 0.5% to 15.23% at 7.5%; corresponding HEK-293 values were 114.30% and 35.44%. Images suggested impaired monolayer gap restoration, and fewer stained-cell aggregates were observed at higher exposures. Supernatant MDA and catalase readouts also varied across conditions. Inconsistencies in replication reporting, an unresolved MTT handling step, possible assay interference, and uncharacterized formulation pH, osmolality, and vehicle limit attribution of these patterns to biological effects. The results are descriptive and do not establish measured cell-survival fractions, oxidative injury mechanisms, tumor selectivity, or clinical biocompatibility. Independent validation in wound-relevant cells with formulation-matched controls is required.
- 7 November 2026
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (11) , 1179
Open AccessCellular Effects of a Topical Hemostatic Agent Used for Acute Bleeding Control: An in Vitro Study in MCF-7 and HEK-293 Cells
This exploratory in vitro study characterized 24 h responses to the topical hemostatic formulation Blood Stoper (TE’SIR) in MCF-7 and HEK-293 cells. Relative MTT reduction was assessed over 0.5–75% (v/v); qualitative scratch-gap observations and 24 h stained-cell aggregate counts were obtained in MCF-7 cells at 0.5%, 1%, and 7.5%, and supernatant malondialdehyde (MDA) and catalase readouts were obtained in both lines. In MCF-7 cells, the reported relative MTT signal declined from 72.61% at 0.5% to 15.23% at 7.5%; corresponding HEK-293 values were 114.30% and 35.44%. Images suggested impaired monolayer gap restoration, and fewer stained-cell aggregates were observed at higher exposures. Supernatant MDA and catalase readouts also varied across conditions. Inconsistencies in replication reporting, an unresolved MTT handling step, possible assay interference, and uncharacterized formulation pH, osmolality, and vehicle limit attribution of these patterns to biological effects. The results are descriptive and do not establish measured cell-survival fractions, oxidative injury mechanisms, tumor selectivity, or clinical biocompatibility. Independent validation in wound-relevant cells with formulation-matched controls is required.
- Open Access
- 30 June 2026
- Published by Galenos Yayinevi in Medeniyet Medical Journal
- Vol. 41 (2) , 219-229
Multimodal Pain Management in Emergency Medicine: A Narrative Review
Pain is one of the most common reasons for presentation to the emergency department, yet it remains frequently undertreated despite effective therapies. Emergency physicians must provide timely analgesia while accounting for diagnostic uncertainty, patient heterogeneity, and safety concerns, particularly related to opioid use.
- 30 June 2026
- Published by Galenos Yayinevi in Medeniyet Medical Journal
- Vol. 41 (2) , 219-229
Open AccessMultimodal Pain Management in Emergency Medicine: A Narrative Review
Pain is one of the most common reasons for presentation to the emergency department, yet it remains frequently undertreated despite effective therapies. Emergency physicians must provide timely analgesia while accounting for diagnostic uncertainty, patient heterogeneity, and safety concerns, particularly related to opioid use.